Loading...

Probi AB (publ)

0GZB.L•LSE
Healthcare
Medical - Pharmaceuticals
£203.00
£-6.00(-2.87%)

Probi AB (publ) (0GZB.L) Stock Overview

Explore Probi AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.5/100

Key Financials

Market Cap2.3B
P/E Ratio233.71
EPS (TTM)$6.54
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

0GZB.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Probi AB (publ) (0GZB.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 233.71 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;